Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyronaridine-artesunate for uncomplicated malaria in Vietnam
ACTRN12618001429246Phase 4Completed
- Sponsor
- US Naval Medical Research Center-Asia and US Naval Medical Research Unit - Two
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of pyronaridine and primaquine in malaria, sponsored by US Naval Medical Research Center-Asia and US Naval Medical Research Unit - Two. Primary endpoints: Parasite clearance time, Fever clearance time and 1 more. Started Jul 2018; status: completed.
02
Drugs
pyronaridineprimaquine
03
Conditions
malaria
Beyond the preview
Go deeper on ACTRN12618001429246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618001429246.